Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

618
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
618
Voltage-gated Ion Channels01:26

Voltage-gated Ion Channels

12.5K
Voltage-gated ion channels are transmembrane proteins that open and close in response to changes in the membrane potential. They are present on the membranes of all electrically excitable cells such as neurons, heart, and muscle cells.
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
12.5K
Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

2.5K
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
2.5K
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

3.9K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
3.9K
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

749
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
749
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

716
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
716

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bone mineral density as a dose-response predictor for osteoporosis: a propensity score analysis of longitudinal incident study (KCIS no. 39).

QJM : monthly journal of the Association of Physicians·2019
Same author

A facile method to functionalize gold nano-tripods with high suspension stability in an aqueous environment.

Nanoscale·2018
Same author

Prevalence rates of youths diagnosed with and medicated for ADHD in a nationwide survey in Taiwan from 2000 to 2011.

Epidemiology and psychiatric sciences·2016
Same author

Saturated fatty acid induces cancer stem cell-like properties in human hepatoma cells.

Cellular and molecular biology (Noisy-le-Grand, France)·2015
Same author

Irritable bowel syndrome and the incidence of colorectal neoplasia: a prospective cohort study with community-based screened population in Taiwan.

British journal of cancer·2014
Same author

Education and imaging. Hepatobiliary and pancreatic: traumatic hepatic arterioportal fistula.

Journal of gastroenterology and hepatology·2011

Related Experiment Video

Updated: Mar 15, 2026

Isolation and Kv Channel Recordings in Murine Atrial and Ventricular Cardiomyocytes
11:33

Isolation and Kv Channel Recordings in Murine Atrial and Ventricular Cardiomyocytes

Published on: March 12, 2013

13.8K

Cardiac Sodium Channel Mutations: Why so Many Phenotypes?

M Liu1, K-C Yang1, S C Dudley1

  • 1The Warren Alpert Medical School of Brown University, Providence, RI, United States.

Current Topics in Membranes
|September 3, 2016
PubMed
Summary

Cardiac sodium channel (Nav1.5) mutations cause various heart conditions. Phenotypic variability arises from modifiers beyond mutations, impacting channel function and disease presentation.

Keywords:
ChannelopathiesGenetic and genomic backgroundGenotype–phenotype variabilityIon homeostasisPosttranslational modifiersTranscriptional modifiersTranslational modifiers

More Related Videos

Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia
09:36

Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia

Published on: December 22, 2023

1.9K
Voltage-Dependent Potassium Current Recording on H9c2 Cardiomyocytes via the Whole-Cell Patch-Clamp Technique
08:11

Voltage-Dependent Potassium Current Recording on H9c2 Cardiomyocytes via the Whole-Cell Patch-Clamp Technique

Published on: November 11, 2022

3.7K

Related Experiment Videos

Last Updated: Mar 15, 2026

Isolation and Kv Channel Recordings in Murine Atrial and Ventricular Cardiomyocytes
11:33

Isolation and Kv Channel Recordings in Murine Atrial and Ventricular Cardiomyocytes

Published on: March 12, 2013

13.8K
Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia
09:36

Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia

Published on: December 22, 2023

1.9K
Voltage-Dependent Potassium Current Recording on H9c2 Cardiomyocytes via the Whole-Cell Patch-Clamp Technique
08:11

Voltage-Dependent Potassium Current Recording on H9c2 Cardiomyocytes via the Whole-Cell Patch-Clamp Technique

Published on: November 11, 2022

3.7K

Area of Science:

  • Cardiology
  • Molecular Biology
  • Genetics

Background:

  • The cardiac sodium channel Nav1.5 is crucial for heart electrical activity, controlling action potential upstroke and duration.
  • Altered Nav1.5 function, due to mutations, can lead to gain-of-function (e.g., Long QT syndrome) or loss-of-function (e.g., Brugada syndrome) channelopathies.
  • Nav1.5 dysfunction influences cardiac conduction velocity and impulse propagation.

Purpose of the Study:

  • To explore factors contributing to the variable clinical presentation of Nav1.5-related heart diseases.
  • To propose that genetic variations and Nav1.5 life cycle alterations modify disease phenotypes.
  • To enhance genotype-phenotype correlations for improved therapeutic strategies.

Main Methods:

  • Review of literature on Nav1.5 channel function, mutations, and associated cardiac conditions.
  • Analysis of factors influencing Nav1.5 channel expression and activity, including post-translational modifications and trafficking.
  • Synthesis of evidence linking genetic variations and Nav1.5 life cycle alterations to phenotypic variability.

Main Results:

  • Nav1.5 mutations are a primary cause of diverse cardiac arrhythmias and cardiomyopathies.
  • Phenotypic variability is significant and influenced by age, gender, temperature, and cardiac region.
  • Potential modifiers include genetic variations and alterations in Nav1.5 transcription, processing, translation, and degradation.

Conclusions:

  • Nav1.5 mutations alone do not fully explain disease phenotypes; additional modifiers are critical.
  • Understanding these modifiers is key to improving genotype-phenotype correlations in cardiac channelopathies.
  • Identifying modifiers may pave the way for novel therapeutic interventions for Nav1.5-related disorders.